Certified by Founder
Lodge
Nomic Bio
start up
Canada
- Montreal, QC
- 18/09/2024
- Series B
- $42,000,000
Nomic (formerly nplex biosciences) is a bioengineering company working to make the human proteome as broadly and easily accessible as the human genome. We are building the nELISA, a next-generation ELISA platform for measuring proteins at scale and at high throughput. The nELISA was designed to seamlessly integrate into current workflows in biology and is uniquely adaptable to a wide variety of use cases within drug and biomarker development workflows. Nomic is headquartered in Montreal, with labs and offices in Boston. For more information, visit www.nomic.bio.
- Industry Biotechnology Research
- Website https://nomic.bio/
- LinkedIn https://www.linkedin.com/company/nomicbio/
Leona Health | $14,000,000 | (Dec 18, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
Codoxo | $35,000,000 | (Dec 18, 2025)
Drive Health | $15,000,000 | (Dec 18, 2025)
DataLane | $22,500,000 | (Dec 18, 2025)
Addition Therapeutics | $100,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)
Scylos | $3,000,000 | (Dec 18, 2025)
Last Energy | $100,000,000 | (Dec 18, 2025)
Limenet | $8,217,860 | (Dec 18, 2025)
Navier AI | $6,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)